RxDoctor Payments Data

Ronald Morton, MD

Otolaryngology · Longview, TXNPI 1346308368

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $44,063 of the $49,950 with a category attached, or 88.2%. Stryker accounts for 98.2% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $19,208 and has fallen 97.9% since, to $401 in 2025. Among otolaryngology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$49,950in general payments, 2019–2025

Across 91 payments — averaging $548.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$49K
  • GSK$361
  • Intersect ENT, Inc.$159
  • Optinose US, Inc.$102
  • Regeneron Healthcare Solutions, Inc.$76
  • Neurent Medical Limited$70
  • plus $150 from 5 others

What the payments were for

  • Consulting fees$44,06388%
  • Travel & lodging$4,0668%
  • Food & beverage$1,8224%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$49,950 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.

See all otolaryngology providers in Texas

Medicare billing

Part B allowed, 2024
$229,728
Medicare patients
360
Services billed
1,349

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide105$4,325
Cefdinir43$728
Mometasone Furoate20$621
Ofloxacin42$595
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav45$554
Prednisone77$174
Mupirocin18$139
Gabapentin16$100
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid14$64
Diazepam17$52
Lorazepam17$22

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Longview

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →